CYTOKINETICS, INCORPORATED Increase (Decrease) in Deferred Revenue
CYTOKINETICS, INCORPORATED (CYTK) reported Increase (Decrease) in Deferred Revenue of $41.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was $0.00.
- CYTOKINETICS, INCORPORATED increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $41.00K.
- CYTOKINETICS, INCORPORATED increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- CYTOKINETICS, INCORPORATED increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $268.00K.
- CYTOKINETICS, INCORPORATED increase (decrease) in deferred revenue for fiscal 2025 was -$50.76M, a 196.92% decline from fiscal 2024.
- CYTOKINETICS, INCORPORATED increase (decrease) in deferred revenue for fiscal 2024 was $52.37M.
- CYTOKINETICS, INCORPORATED increase (decrease) in deferred revenue for fiscal 2023 was $0.00.
- CYTOKINETICS, INCORPORATED increase (decrease) in deferred revenue for fiscal 2022 was -$87.00M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 167 month | Increase (Decrease) in Deferred Revenue 182 month | Increase (Decrease) in Deferred Revenue 191 month | Increase (Decrease) in Deferred Revenue 194 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $41.00K 10-Q · filed 2026-08-06 | $41.00K derived: sum of 3 quarters · filed 2026-08-06 | $309.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $41.00K 10-Q · filed 2026-05-05 | $41.00K derived: sum of 2 quarters · filed 2026-05-05 | $309.00K derived: sum of 3 quarters · filed 2026-05-05 | -$50.72M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $268.00K derived: sum of 2 quarters · filed 2026-02-26 | -$50.76M derived: sum of 3 quarters · filed 2026-08-06 | -$50.76M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$50.76M derived: sum of 2 quarters · filed 2026-08-06 | -$50.76M 10-Q · filed 2025-11-05 | $1.61M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$51.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$51.03M 10-Q · filed 2026-08-06 | $1.34M derived: sum of 3 quarters · filed 2026-08-06 | $1.34M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-05 | $52.37M derived: sum of 2 quarters · filed 2026-05-05 | $52.37M derived: sum of 3 quarters · filed 2026-05-05 | |||||
| 2024-12-31 | $52.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $52.37M derived: sum of 2 quarters · filed 2026-02-26 | $52.37M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||||||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | |||||||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | |||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | -$87.00M 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$87.00M 10-Q · filed 2023-11-03 | ||||||
| 2022-06-30 | -$87.00M 10-Q · filed 2023-08-03 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | |||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | ||||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-05 | |||||||
| 2020-12-31 | $87.00M 10-K · filed 2023-03-01 | |||||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-25 | |||||||
| 2018-12-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $3.09M derived: sum of 2 quarters · filed 2021-02-26 | -$4.75M derived: sum of 3 quarters · filed 2021-02-26 | -$6.49M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | -$4.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$12.01M derived: sum of 2 quarters · filed 2018-11-09 | -$13.74M 10-Q · filed 2018-11-09 | -$14.61M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2018-06-30 | -$7.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$9.57M 10-Q · filed 2018-08-07 | -$10.44M derived: sum of 3 quarters · filed 2018-08-07 | -$8.01M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2018-03-31 | -$1.73M 10-Q · filed 2018-05-10 | -$2.60M derived: sum of 2 quarters · filed 2018-05-10 | -$167.00K derived: sum of 3 quarters · filed 2018-11-09 | -$3.13M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-12-31 | -$870.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $1.56M derived: sum of 2 quarters · filed 2018-11-09 | -$1.40M derived: sum of 3 quarters · filed 2018-11-09 | $1.51M 10-K · filed 2018-03-05 | ||||
| 2017-09-30 | $2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$532.00K derived: sum of 2 quarters · filed 2018-11-09 | $2.38M 10-Q · filed 2018-11-09 | -$690.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | -$2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$51.00K 10-Q · filed 2018-08-07 | -$3.12M derived: sum of 3 quarters · filed 2018-08-07 | $8.18M derived: sum of 4 quarters · filed 2018-08-07 | ||||
| 2017-03-31 | $2.92M 10-Q · filed 2018-05-10 | -$158.00K derived: sum of 2 quarters · filed 2018-05-10 | $11.14M derived: sum of 3 quarters · filed 2018-05-10 | $9.21M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $8.23M derived: sum of 2 quarters · filed 2018-03-05 | $6.30M derived: sum of 3 quarters · filed 2018-03-05 | $2.20M 10-K · filed 2018-03-05 | ||||
| 2016-09-30 | $11.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $9.37M derived: sum of 2 quarters · filed 2017-11-03 | $5.28M 10-Q · filed 2017-11-03 | $421.00K derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2016-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$6.02M 10-Q · filed 2017-08-04 | -$10.88M derived: sum of 3 quarters · filed 2018-03-05 | -$14.45M derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2016-03-31 | -$4.09M 10-Q · filed 2017-05-04 | -$8.95M derived: sum of 2 quarters · filed 2018-03-05 | -$12.52M derived: sum of 3 quarters · filed 2018-03-05 | -$15.39M derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2015-12-31 | -$4.85M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-05 | -$8.43M derived: sum of 2 quarters · filed 2018-03-05 | -$11.29M derived: sum of 3 quarters · filed 2018-03-05 | -$12.74M 10-K · filed 2018-03-05 | ||||
| 2015-09-30 | -$3.57M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2016-12-15 | -$6.44M derived: sum of 2 quarters · filed 2016-12-15 | -$7.89M 10-Q/A · filed 2016-12-15 | $20.38M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-06-30 | -$2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$4.31M 10-Q · filed 2016-08-04 | $23.95M derived: sum of 3 quarters · filed 2017-03-06 | $20.30M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-03-31 | -$1.45M 10-Q · filed 2016-05-05 | $26.82M derived: sum of 2 quarters · filed 2017-03-06 | $23.17M derived: sum of 3 quarters · filed 2017-03-06 | $20.98M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2014-12-31 | $28.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $24.62M derived: sum of 2 quarters · filed 2017-03-06 | $22.43M derived: sum of 3 quarters · filed 2017-03-06 | $17.40M 10-K · filed 2017-03-06 | ||||
| 2014-09-30 | -$3.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$5.83M derived: sum of 2 quarters · filed 2015-11-05 | -$10.87M 10-Q · filed 2015-11-05 | -$30.68M derived: sum of 4 quarters · filed 2016-03-03 | ||||
| 2014-06-30 | -$2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$7.22M 10-Q · filed 2015-08-05 | -$27.03M derived: sum of 3 quarters · filed 2016-03-03 | -$24.55M derived: sum of 4 quarters · filed 2016-03-03 | ||||
| 2014-03-31 | -$5.03M 10-Q · filed 2015-05-04 | -$24.85M derived: sum of 2 quarters · filed 2016-03-03 | -$22.36M derived: sum of 3 quarters · filed 2016-03-03 | |||||
| 2013-12-31 | -$19.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$17.33M derived: sum of 2 quarters · filed 2016-03-03 | $16.20M 10-K · filed 2016-03-03 | |||||
| 2013-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $36.02M 10-Q · filed 2014-11-06 | $36.02M 10-Q · filed 2013-11-06 | |||||
| 2013-06-30 | $33.53M 10-Q · filed 2014-08-07 | $33.53M 10-Q · filed 2013-08-07 | ||||||
| 2012-12-31 | -$129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $0.00 10-K · filed 2015-03-06 | ||||||
| 2012-09-30 | $129.00K 10-Q · filed 2013-11-06 | $129.00K 10-Q · filed 2012-11-07 | ||||||
| 2011-06-30 | $246.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $263.00K 10-Q · filed 2012-08-06 | $263.00K derived: sum of 3 quarters · filed 2013-03-15 | $263.00K derived: sum of 4 quarters · filed 2013-03-15 | $263.00K 10-Q · filed 2011-08-04 | |||
| 2011-03-31 | $17.00K 10-Q · filed 2012-05-04 | $17.00K derived: sum of 2 quarters · filed 2013-03-15 | $17.00K derived: sum of 3 quarters · filed 2013-03-15 | |||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $0.00 derived: sum of 2 quarters · filed 2013-03-15 | -$751.00K 10-K · filed 2013-03-15 | |||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$751.00K 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | -$751.00K 10-Q · filed 2011-08-04 | |||||||
| 2009-12-31 | -$23.74M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |